IP Library Granted Patent US 7,344,856
Granted Patent B1
US 7,344,856 · App. 09/674,777 · Granted Mar 18, 2008

Method of controlling cleavage by OmpT protease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,344,856
App. No.
09/674,777
Granted
Mar 18, 2008
Kind
B1
Abstract

Methods of using OmpT protease are provided. In particular, the invention provides for a method of controlling cleavage of a polypeptide by OmpT protease comprising, converting a sequence site comprising two arbitrary consecutive amino acids and/or amino acid(s) in the vicinity of the site in the polypeptide into other amino acids; which method comprises setting lysine or arginine as the amino acid at the −1-position concerning the site and setting a specific amino acid as the amino acid at the +1-position; and/or setting specific amino acid(s) as the amino acid(s) at the −4-position and/or the −6-position relative to the site; so that a desired part of the polypeptide is cleaved by OmpT protease and/or an undesired part of the polypeptide is not (or hardly) cleaved by OmpT protease. A method of producing a target polypeptide is also provided.

Claims (19)

1. A method for elevating the cleavage efficiency of E. coli OmpT protease on a polypeptide at a sequence site, −1 and +1 positions, which is originally cleavable by E. coli OmpT protease, comprising setting an amino acid other than acidic amino acids as the amino acid at the −4-position and/or the −6-position relative to said sequence site in said polypeptide.

2. A method for elevating the cleavage efficiency of E. coli OmpT protease on a polypeptide at a sequence site, −1 and +1 positions, which is originally cleavable by E. coli OmpT protease, comprising amino acid conversion in the polypeptide by, in a case where the amino acid at the −4 and/or −6 position relative to said sequence site is an acidic amino acid, setting a neutral amino acid or a basic amino acid as said amino acid at the −4 and/or −6 position, or in a case where the amino acid at the −4 and/or −6 position is a neutral amino acid, setting a basic amino acid as said amino acid at the −4 and/or −6 position.

3. A method for elevating the cleavage efficiency of E. coli OmpT protease on a polypeptide having a sequence site which consists of two arbitrary consecutive amino acids at −1 and +1 positions and which is cleavable by E. coli OmpT protease, wherein said method comprises:

(1) setting lysine or arginine as the amino acid at the −1-position of said site,

(2) setting an amino acid X, wherein X is an amino acid other than glutamic acid, aspartic acid or proline, as the amino acid at the +1-position, and

(3) amino acid conversion to set an amino acid other than acidic amino acids as the amino acid at the −4-position and/or the −6-position relative to said sequence site.

4. A method for elevating the cleavage efficiency of E. coli OmpT protease on a polypeptide having a sequence site which consists of two arbitrary consecutive amino acids at −1 and +1 positions and which is cleavable by E. coli OmpT protease, which method comprises:

(1) setting lysine or arginine as the amino acid at the −1-position of said site, setting an amino acid X, wherein X is an amino acid other than glutamic acid, aspartic acid or proline, as the amino acid at the +1-position, and

(2) in a case where the amino acid at the −4 and/or −6 position relative to said sequence site is an acidic amino acid, converting said amino acid at the −4 and/or −6 position to a neutral amino acid or a basic amino acid, or in a case where the amino acid at the −4 and/or −6 position is a neutral amino acid, converting said amino acid at the −4 and/or −6 position to a basic amino acid.

5. The method of any one of claims 1 , 2 , 3 , and 4 , wherein a basic amino acid is set as the amino acid at −4 and/or −6 position relative to the sequence site.

6. A method for lowering the cleavage efficiency of E. coli OmpT protease on a polypeptide at a sequence site, −1 and +1 positions, which is originally cleavable by E. coli OmpT protease, comprising amino acid conversion in the polypeptide by setting a neutral amino acid or an acidic amino acid as the amino acid at the −4-position and/or the −6-position relative to said sequence site.

7. A method for lowering the cleavage efficiency of E. coli OmpT protease on a polypeptide having a sequence site which consists of two arbitrary consecutive amino acids at −1 and +1 positions and which is cleavable by E. coli OmpT protease, which method comprises:

(1) setting lysine or arginine as the amino acid at the −1-position of said site, setting an amino acid X, wherein X is an amino acid other than glutamic acid, aspartic acid or proline, as the amino acid at the +1-position, and

(2) amino acid conversion to set a neutral amino acid or an acidic amino acid as the amino acid at the −4-position and/or the −6-position relative to said sequence site.

8. A method for lowering the cleavage efficiency of E. coli OmpT protease on a polypeptide at a sequence site, −1 and +1 positions, which is originally cleavable by E. coli OmpT protease, comprising amino acid conversion in the polypeptide by in a case where the amino acid at the −4 and/or −6 position relative to said sequence site is a basic amino acid, setting a neutral amino acid or an acidic amino acid as said amino acid at the −4 and/or −6 position, or in a case where the amino acid at the −4 and/or −6 position is a neutral amino acid, setting an acidic amino acid as said amino acid at the −4 and/or −6 position.

9. A method for lowering the cleavage efficiency of E. coli OmpT protease on a polypeptide having a sequence site which consists of two arbitrary consecutive amino acids at −1 and +1 positions and which is cleavable by E. coli OmpT protease, wherein the method comprises:

(1) setting lysine or arginine as the amino acid at the −1-position of said site, setting an amino acid X, wherein X is an amino acid other than glutamic acid, aspartic acid or proline, as the amino acid at the +1-position, and

(2) in a case where the amino acid at the −4 and/or −6 position relative to said sequence site is a basic amino acid, converting said amino acid at the −4 and/or −6 position to a neutral amino acid or an acidic amino acid, or in a case where the amino acid at the −4 and/or −6 position is a neutral amino acid, converting said amino acid at the −4 and/or −6 position to an acidic amino acid.

10. The method of any one of claims 6 - 9 , wherein an acidic amino acid is set as the amino acid at the −4 and/or −6 position relative to the sequence site.

Assignments (3)
CHANGE OF NAME Recorded Apr 30, 2007
From: DAIICHI ASUBIO PHARMA CO., LTD.
To: ASUBIO PHARMA CO., LTD.
Reel/Frame 019229/0039 →
CHANGE OF NAME TO CORRECT ADDRESS OF RECEIVING PARTY TO RECITE "TOKYO" - REEL/FRAME: 017279/0094 Recorded Apr 4, 2006
From: DAIICHI SUNTORY PHARMA CO., LTD.
To: DAIICHI ASUBIO PHARMA CO., LTD.
Reel/Frame 017433/0745 →
CHANGE OF NAME Recorded Oct 31, 2005
From: DAIICHI SUNTORY PHARMA CO., LTD.
To: DAIICHI ASUBIO PHARMA CO., LTD.
Reel/Frame 017279/0094 →